Arena Pharma (ARNA) Misses Q2 EPS by 7626c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Financial Fact:
Research and development: 17.47M
Today's EPS Names:
PKE, BYRN, HELE, More
Financial Fact:
Research and development: 17.47M
Today's EPS Names:
PKE, BYRN, HELE, More
Join SI Premium – FREE
Arena Pharma (NASDAQ: ARNA) reported Q2 EPS of ($77.00), $76.26 worse than the analyst estimate of ($0.74). Revenue for the quarter came in at $6.5 million versus the consensus estimate of $5.52 million.
For earnings history and earnings-related data on Arena Pharma (ARNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana soars, Alignment Healthcare sinks on Medicare rating changes
- Diamondback Energy reports Q3 2026 realized prices and derivative losses
- Neogen Corp. (NEOG) Tops Q1 EPS by 3c; raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
